View Clinical Trial (Medical Research Study)
Smoking Cessation Treatment for Head and Neck Cancer Patients
| City: |
|
New Haven |
| State: |
|
Connecticut |
| Zip Code: |
|
06511 |
| Conditions: |
|
Smoking Cessation |
| Purpose: |
|
This is a pilot research study examining the use of varenicline (Chantix) and the nicotine
patch. The study is designed to find out whether one of these medications is more effective
for smoking cessation with head and neck cancer patients. The study has three parts: 1) two
intake sessions; 2) an 8-week treatment phase, and 3) a 3-month follow-up.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- age 18 or older
- smoking 10 or more cigarettes per day
- diagnosed with and completed an initial course of treatment for any type of head and
neck cancer
- life expectancy of 12 months or more
Exclusion Criteria:
- history of allergic reactions to adhesives
- unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis,
severe alcohol dependence, or dementia
- females of childbearing potential who are pregnant, nursing, or not practicing
effective contraception
|
| NCT ID: |
|
NCT00931021 |
| Primary Contact: |
|
Principal Investigator
Benjamin Toll, Ph.D.
Yale University
Benjamin Toll, Ph.D.
Phone: 203-974-5767
Email: benjamin.toll@yale.edu
|
| Backup Contact: |
|
Email: susan.neveu@yale.edu
Susan Neveu
Phone: 203-974-5768
|
| Location Contact: |
|
New Haven, Connecticut 06511
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 20, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|